Skip to content
10-Q

Quarterly Report

AMERICAN ORIENTAL BIOENGINEERING INC

0001019687-14-000311

← back to feed
Filed
Jan 30, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Jan 21, 2014 36.57M sh
Shares Diluted Q3 2013 · Sep 30, 2013 36.54M sh
Shares Diluted Q3 2013 · Sep 30, 2013 36.56M sh
Shares Diluted Q3 2013 · Sep 30, 2012 38.29M sh
Shares Diluted Q3 2013 · Sep 30, 2012 38.72M sh
Stock Repurchased Q3 2013 · Sep 30, 2013 $0
Stock Repurchased Q3 2013 · Sep 30, 2012 $1.27M
Capex Q3 2013 · Sep 30, 2013 $15.12M
Capex Q3 2013 · Sep 30, 2012 $9.35M
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$21.93M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$37.14M
Long Term Debt Q3 2013 · Sep 30, 2013 $5.06M
Long Term Debt Q3 2013 · Dec 31, 2012 $554.59K
Short Term Debt Q3 2013 · Sep 30, 2013 $66.01K
Short Term Debt Q3 2013 · Dec 31, 2012 $64.81K
Cash And Equivalents Q3 2013 · Sep 30, 2013 $3.23M
Cash And Equivalents Q3 2013 · Dec 31, 2012 $7.1M
Cash And Equivalents Q3 2013 · Sep 30, 2012 $26.43M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $52.63M
Stockholders Equity Q3 2013 · Sep 30, 2013 $283.68M
Stockholders Equity Q3 2013 · Dec 31, 2012 $327.59M
Current Liabilities Q3 2013 · Sep 30, 2013 $126.31M
Current Liabilities Q3 2013 · Dec 31, 2012 $106.21M
Total Liabilities Q3 2013 · Sep 30, 2013 $143.95M
Total Liabilities Q3 2013 · Dec 31, 2012 $118.72M
Current Assets Q3 2013 · Sep 30, 2013 $64.78M
Current Assets Q3 2013 · Dec 31, 2012 $95.45M
Total Assets Q3 2013 · Sep 30, 2013 $427.62M
Total Assets Q3 2013 · Dec 31, 2012 $446.31M
Eps Diluted Q3 2013 · Sep 30, 2013 −$0.58
Eps Diluted Q3 2013 · Sep 30, 2013 −$1.51
Eps Diluted Q3 2013 · Sep 30, 2012 $0.50
Eps Diluted Q3 2013 · Sep 30, 2012 −$0.62
Eps Basic Q3 2013 · Sep 30, 2013 −$0.58
Eps Basic Q3 2013 · Sep 30, 2013 −$1.51
Eps Basic Q3 2013 · Sep 30, 2012 $0.51
Eps Basic Q3 2013 · Sep 30, 2012 −$0.62
Sga Expense Q3 2013 · Sep 30, 2013 $9.5M
Sga Expense Q3 2013 · Sep 30, 2013 $32.99M
Sga Expense Q3 2013 · Sep 30, 2012 $12.01M
Sga Expense Q3 2013 · Sep 30, 2012 $36.05M
Rd Expense Q3 2013 · Sep 30, 2013 $3.25M
Rd Expense Q3 2013 · Sep 30, 2013 $6.37M
Rd Expense Q3 2013 · Sep 30, 2012 $1.68M
Rd Expense Q3 2013 · Sep 30, 2012 $4.98M
Net Income Q3 2013 · Sep 30, 2013 −$21.18M
Net Income Q3 2013 · Sep 30, 2013 −$55.13M
Net Income Q3 2013 · Sep 30, 2012 $19.12M
Net Income Q3 2013 · Sep 30, 2012 −$23.83M
Operating Income Q3 2013 · Sep 30, 2013 −$18.97M
Operating Income Q3 2013 · Sep 30, 2013 −$48.31M
Operating Income Q3 2013 · Sep 30, 2012 −$19.2M
Operating Income Q3 2013 · Sep 30, 2012 −$56.51M
Gross Profit Q3 2013 · Sep 30, 2013 $3.11M
Gross Profit Q3 2013 · Sep 30, 2013 $12.59M
Gross Profit Q3 2013 · Sep 30, 2012 $6.46M
Gross Profit Q3 2013 · Sep 30, 2012 $17.33M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $14.83M
Cost Of Revenue Q3 2013 · Sep 30, 2013 $46.57M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $23.04M
Cost Of Revenue Q3 2013 · Sep 30, 2012 $65.36M
Revenue Q3 2013 · Sep 30, 2013 $17.94M
Revenue Q3 2013 · Sep 30, 2013 $59.17M
Revenue Q3 2013 · Sep 30, 2012 $29.49M
Revenue Q3 2013 · Sep 30, 2012 $82.69M